Sensible Biotechnologies Analysis: $4M Raised
What is Sensible Biotechnologies?
Sensible Biotechnologies develops innovative mRNA manufacturing technologies for cost-efficient production of high-quality, non-immunogenic mRNA therapeutics and vaccines.
Employees
22
Founded
2021
Revenue
$1.3M
Company Stage
Pre-Seed
YC Batch
S21
Product Features & Capabilities
- non-immunogenic mRNA, pure and highly functional mRNA, long mRNA for novel modalities, naturally modified mRNA for increased efficacy, cost-effective mRNA manufacturing, scalable mRNA production, cell-based platform for mRNA vaccines and therapeutics
How much Sensible Biotechnologies raised
Pre-Seed - $4.2 million
23 months agoLead Investor: Not specified in the sources.
Who are the founders of Sensible Biotechnologies
MG
Investors
- Sensible Biotechnologies raised $4.2 million in a pre-seed financing round.
- The investors involved in this round include:
